Related Experiment Video
Updated: May 12, 2025

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
Non-linear relationship between Dietary Inflammatory Index and constipation: threshold identification and insights
Shuxun Wei1, Jin Qian1, Minghao Zou1
1The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Navy Medical University, Shanghai, China.
Background:
With the acceleration of the pace of life and changes in dietary habits, functional gastrointestinal disorders, especially constipation, have become a significant public health issue affecting health and quality of life of people worldwide. Given the limitations of traditional treatments, adjusting dietary structure has become a more economical and convenient therapeutic approach. We aimed to explore the associations between the Dietary Inflammatory Index (DII) and constipation in this study.
Methods:
This study was based on the National Health and Nutrition Examination Survey (NHANES) data from 2005-2010, utilizing bowel movement frequency and stool characteristics questionnaires to determine constipation status, and calculating the DII based on 24-hour dietary recall data. To assess the relationship between the DII and constipation, we employed three models, which were further explored through inverse probability of treatment weighting (IPTW), restricted cubic splines (RCS) analysis, and Mendelian randomization.
Results:
Individuals with a higher DII exhibited a higher risk of constipation. In the unadjusted model, participants in the highest quartile (Q4) had a 2.85-fold increased risk of constipation compared to those in the lowest quartile (Q1) [odds ratio (OR): 2.85; 95% confidence interval (CI): 1.78-4.56; P<0.001], with similar results observed in various adjusted models and IPTW adjusted models. RCS analysis revealed a nonlinear relationship between the DII and constipation, with a threshold value (DII =0.974) beyond which the risk of constipation significantly increased. Subgroup analysis showed that gender, income level, and diabetes status affected the relationship between the DII and constipation. Mendelian randomization analysis did not find any significant causal relationships for components of the DII, except for energy intake.
Conclusions:
There is a nonlinear relationship between the DII and the risk of constipation, with a threshold value of 0.974, and differences in the risk of constipation associated with the DII across different income, gender, and diabetes status groups. These findings provide a basis for using the DII as a strategy for the prevention and intervention of constipation.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Constipation-Predominant IBS
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...